Pediatrix Medical
MD
Market cap $1.1B

12.82 USD

+0.01

0.08%

At close Jul 16, 4:00 PM EDT

After hours

12.82

+0.00

0.00%

1 day

0.08%

5 days

-4.83%

1 month

-7.24%

3 months

-2.44%

6 months

-6.90%

Year to date

-1.61%

1 year

68.24%

5 years

-31.81%

10 years

-83.59%

About: Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.

Employees: 4,485

Healthcare Medical Care Facilities

0

Funds holding %

of 7,317 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

2,331% more call options, than puts

Call options by funds: $2.67M | Put options by funds: $110K

85% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 20

7% more capital invested

Capital invested by funds: $1.08B [Q4 2024] → $1.16B (+$80.5M) [Q1 2025]

5% more funds holding

Funds holding: 228 [Q4 2024] → 239 (+11) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]

5% less repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 83

2.42% less ownership

Funds ownership: 95.82% [Q4 2024] → 93.4% (-2.42%) [Q1 2025]

See Fund Rankings

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$16

25%

upside

Avg. target

$18

40%

upside

High target

$20

56%

upside

2 analyst ratings

1 positive

50%

1 neutral

50%

0 negative

0%

UBS A.J. Rice	25%upside $16	Neutral Maintained	12 May 2025
Macquarie Tao Qiu	56%upside $20	Outperform Maintained	8 May 2025

See Analyst Rankings

Financial journalist opinion

Based on 4 articles about MD published over the past 30 days

Zacks Investment Research

Here's Why Pediatrix Medical Group (MD) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Pediatrix Medical Group (MD) is a Strong Value Stock

Pediatrix Board Appoints Kurt D. Newman, M.D.

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Board Appoints Kurt D. Newman, M.D. as Independent Director.

Pediatrix Board Appoints Kurt D. Newman, M.D.

Zacks Investment Research

MD or HQY: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical Services sector have probably already heard of Pediatrix Medical Group (MD) and HealthEquity (HQY). But which of these two companies is the best option for those looking for undervalued stocks?

MD or HQY: Which Is the Better Value Stock Right Now?

Zacks Investment Research

Why Pediatrix Medical Group (MD) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why Pediatrix Medical Group (MD) is a Top Value Stock for the Long-Term

Zacks Investment Research

Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term

Zacks Investment Research

MD or HQY: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or HealthEquity (HQY). But which of these two companies is the best option for those looking for undervalued stocks?

MD or HQY: Which Is the Better Value Stock Right Now?

Zacks Investment Research

Here's Why You Should Add Pediatrix Medical to Your Portfolio Now

MD rises 5.6% YTD as earnings beat, hospital deals and lower costs drive growth. The Zacks Rank #2 signals strong near-term prospects.

Here's Why You Should Add Pediatrix Medical to Your Portfolio Now

Zacks Investment Research

Wall Street Analysts See a 26.4% Upside in Pediatrix Medical Group (MD): Can the Stock Really Move This High?

The mean of analysts' price targets for Pediatrix Medical Group (MD) points to a 26.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Wall Street Analysts See a 26.4% Upside in Pediatrix Medical Group (MD): Can the Stock Really Move This High?

Zacks Investment Research

MD vs. HQY: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or HealthEquity (HQY). But which of these two stocks presents investors with the better value opportunity right now?

MD vs. HQY: Which Stock Is the Better Value Option?

Zacks Investment Research

Pediatrix Medical Group (MD) Shows Fast-paced Momentum But Is Still a Bargain Stock

Pediatrix Medical Group (MD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Pediatrix Medical Group (MD) Shows Fast-paced Momentum But Is Still a Bargain Stock

See News Rankings

Charts implemented using Lightweight Charts™